1.53
price down icon8.93%   -0.15
after-market Dopo l'orario di chiusura: 1.58 0.05 +3.27%
loading
Precedente Chiudi:
$1.68
Aprire:
$1.68
Volume 24 ore:
151.30K
Relative Volume:
0.06
Capitalizzazione di mercato:
$43.48M
Reddito:
-
Utile/perdita netta:
$-87.23M
Rapporto P/E:
-0.5152
EPS:
-2.97
Flusso di cassa netto:
$-82.77M
1 W Prestazione:
+15.04%
1M Prestazione:
+1.32%
6M Prestazione:
-80.08%
1 anno Prestazione:
-86.92%
Intervallo 1D:
Value
$1.515
$1.68
Intervallo di 1 settimana:
Value
$1.28
$1.78
Portata 52W:
Value
$0.8801
$19.30

Pepgen Inc Stock (PEPG) Company Profile

Name
Nome
Pepgen Inc
Name
Telefono
703-456-8000
Name
Indirizzo
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Name
Dipendente
81
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-08
Name
Ultimi documenti SEC
Name
PEPG's Discussions on Twitter

Confronta PEPG con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PEPG
Pepgen Inc
1.53 43.48M 0 -87.23M -82.77M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.89B 3.81B -644.79M -669.77M -6.24

Pepgen Inc Stock (PEPG) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-16 Downgrade BofA Securities Neutral → Underperform
2024-07-31 Downgrade BofA Securities Buy → Neutral
2022-12-21 Iniziato H.C. Wainwright Buy

Pepgen Inc Borsa (PEPG) Ultime notizie

pulisher
04:54 AM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - GlobeNewswire Inc.

04:54 AM
pulisher
04:11 AM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - Bluefield Daily Telegraph

04:11 AM
pulisher
Apr 22, 2025

PepGen Inc. CEO Makes Bold Stock Purchase! - TipRanks

Apr 22, 2025
pulisher
Apr 15, 2025

Is PepGen (NASDAQ:PEPG) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Apr 15, 2025
pulisher
Apr 09, 2025

PepGen Inc.’s CEO Makes Bold Stock Purchase! - TipRanks

Apr 09, 2025
pulisher
Apr 09, 2025

PepGen president and CEO McArthur buys shares worth $47,724 By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

PepGen president and CEO McArthur buys shares worth $47,724 - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 05, 2025

PepGen stock plunges to 52-week low of $1.14 amid market challenges - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

PepGen stock plunges to 52-week low of $1.14 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

PepGen (NASDAQ:PEPG) Stock Price Down 14.4% – Time to Sell? - Defense World

Apr 04, 2025
pulisher
Apr 02, 2025

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 02, 2025
pulisher
Apr 01, 2025

PepGen Announces Appointment of Two New Directors to its Board - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

PepGen Appoints Lisa Wyman and Mitchell Finer to its Board of Directors - citybiz

Mar 31, 2025
pulisher
Mar 31, 2025

PepGen Inc. Expands Board with New Appointments - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

PepGen names two new directors to board - TipRanks

Mar 31, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen IncPEPG - Bluefield Daily Telegraph

Mar 26, 2025
pulisher
Mar 18, 2025

PEPG ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of PepGen Inc. Shareholders Who Lost Money - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 10, 2025

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - Business Wire

Mar 10, 2025
pulisher
Mar 10, 2025

PepGen Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsPEPG - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 05, 2025

PepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

What Do Analysts Think Will Happen To PepGen Inc (NASDAQ: PEPG) - Stocks Register

Mar 05, 2025
pulisher
Mar 05, 2025

PepGen to Participate in Upcoming March 2025 Investor Conferences - BioSpace

Mar 05, 2025
pulisher
Mar 04, 2025

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Boston biotech's stock drops after Duchenne trial pause - The Business Journals

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to pause CONNECT2-EDO51 study - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen slumps after pausing mid-stage study of Duchenne drug - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen pauses phase 2 DMD study to review earlier trial data - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD -March 04, 2025 at 08:18 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen stock slides after trial pause (PEPG:NASDAQ) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to Participate in Upcoming Investor Conferences - Business Wire

Mar 04, 2025
pulisher
Mar 04, 2025

AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - Asianet Newsable

Mar 04, 2025
pulisher
Mar 03, 2025

PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz? - Asianet Newsable

Mar 03, 2025
pulisher
Mar 03, 2025

PepGen (PEPG) to Release Quarterly Earnings on Wednesday - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

PEPG Stock Price and Chart — NASDAQ:PEPG - TradingView

Mar 02, 2025

Pepgen Inc Azioni (PEPG) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):